Somnus Therapeutics Inc.
135 Route 202/206
Bedminster
New Jersey
07921
United States
Tel: 908-901-0300
9 articles about Somnus Therapeutics Inc.
-
Somnus Therapeutics Inc. Seeks Buyer for Insomnia Drug that Treats Midnight Awakenings
6/15/2011
-
Somnus Therapeutics Inc. Release: Phase 2 Study of SKP-1041 for Sleep Maintenance Insomnia Shows Significant Reduction of Mid-Night Awakenings without Next-Day Cognitive Impairment
6/15/2011
-
Somnus Therapeutics Inc. Awarded QTDP Grant for Clinical Trials of SKP-1041 Sleep Maintenance Insomnia Therapy
11/4/2010
-
Somnus Therapeutics Inc. Developing Medication to Prevent Middle-of-the-Night Awakening with No Adverse Effects on Next Day Performance
6/9/2010
-
Somnus Therapeutics Inc. Raises $15 Million
2/11/2010
-
Somnus Therapeutics Inc. Release: Presented at SLEEP 2009: New Controlled-Release Formulations of Proven Drug Being Developed for Middle-of-the-Night Awakening
6/8/2009
-
Skyepharma PLC And Somnus Therapeutics Inc. - Research Update
12/11/2008
-
Somnus Therapeutics Inc. Introduces Its Scientific Advisory Board
11/6/2008
-
Somnus Therapeutics Inc. Announces Initial Board of Directors
9/16/2008